FOLFOX has been shown to ameliorate CD8+ T lymphocyte exhaustion, induce tumor infiltration of activated PD-1+ CD8+ T cells, and suppress myeloid-derived suppressor cells (MDSCs), all of which contributed to enhanced anti-PD-1 efficacy in mouse models (29–31). Here, CD8A is linked to neoplasm.